Home
Random
Nearby
Log in
Settings
Donate
About Wikidata
Disclaimers
Search
(Q34604396)
Watch
English
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone.
scientific article
In more languages
edit
Statements
instance of
scholarly article
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
review article
1 reference
stated in
Europe PubMed Central
title
Drug Insight: clinical use of agonists and antagonists of luteinizing-hormone-releasing hormone
(English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
author
Jörg B. Engel
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
Andrew Schally
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
author name string
Jörg B Engel
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
retrieved
3 August 2017
publication date
1 February 2007
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
published in
Nature Clinical Practice Endocrinology and Metabolism
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
volume
3
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
issue
2
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
page(s)
157-167
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
cites work
Single-therapy androgen suppression in men with advanced prostate cancer: a systematic review and meta-analysis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
21 January 2018
Hormone treatment of endometriosis: the estrogen threshold hypothesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
21 January 2018
Structure of the porcine LH- and FSH-releasing hormone. I. The proposed amino acid sequence
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gonadotropin-releasing hormone: one polypeptide regulates secretion of luteinizing and follicle-stimulating hormones
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypothalamic Follicle-Stimulating Hormone (FSH) and Luteinizing Hormone (LH)-Regulating Hormone: Structure, Physiology, and Clinical Studies**The work described here has been supported by research grants from the Veterans Administration, United State
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Luteinizing hormone-releasing hormone analogs: their impact on the control of tumorigenesis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Second gene for gonadotropin-releasing hormone in humans
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Human type II GnRH receptor mediates effects of GnRH on cell proliferation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Hypothalamic hormones and cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The use of luteinizing hormone releasing hormone agonists and antagonists in gynaecological cancers
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The gonadotrophin-releasing hormone receptor: signalling, cycling and desensitisation
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A phase 3, multicenter, open label, randomized study of abarelix versus leuprolide plus daily antiandrogen in men with prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effects of long-term treatment with the luteinizing hormone-releasing hormone (LHRH) agonist Decapeptyl and the LHRH antagonist Cetrorelix on the levels of pituitary LHRH receptors and their mRNA expression in rats
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effect of long-term treatment with low doses of the LHRH antagonist Cetrorelix on pituitary receptors for LHRH and gonadal axis in male and female rats.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gonadotropin-Releasing Hormone (GnRH)-Binding Sites in Human Breast Cancer Cell Lines and Inhibitory Effects of GnRH Antagonists*
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Primary and salvage therapy with LH-RH analogues in ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Growth of human breast cancer cells inhibited by a luteinizing hormone-releasing hormone agonist
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of growth of human mammary tumor cells by potent antagonists of luteinizing hormone-releasing hormone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibitory activity of luteinizing hormone-releasing hormone on tumor growth and progression.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Antiproliferative effects of the GnRH antagonist cetrorelix and of GnRH-II on human endometrial and ovarian cancer cells are not mediated through the GnRH type I receptor
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Tumor growth inhibition in patients with prostatic carcinoma treated with luteinizing hormone-releasing hormone agonists
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
A review of studies of hormonal adjuvant therapy in prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intermittent Androgen Deprivation for Patients With Recurrent/Metastatic Prostate Cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Radiation and hormonal therapy for locally advanced and clinically localized prostate cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Three-month neoadjuvant hormonal therapy before radical prostatectomy: a 7-year follow-up of a randomized controlled trial
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Neoadjuvant therapy before radical prostatectomy for clinical T3/T4 carcinoma of the prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Inhibition of luteinizing hormone, follicle-stimulating hormone and sex-steroid levels in men and women with a potent antagonist analog of luteinizing hormone-releasing hormone, Cetrorelix (SB-75)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Luteinizing hormone-releasing hormone antagonist cetrorelix as primary single therapy in patients with advanced prostatic cancer and paraplegia due to metastatic invasion of spinal cord
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Goserelin, a depot gonadotrophin-releasing hormone agonist in the treatment of premenopausal patients with metastatic breast cancer. German Zoladex Trial Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment with a luteinising-hormone-releasing-hormone analogue (buserelin) in premenopausal patients with metastatic breast cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined treatment with buserelin and tamoxifen in premenopausal metastatic breast cancer: a randomized study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Combined tamoxifen and luteinizing hormone-releasing hormone (LHRH) agonist versus LHRH agonist alone in premenopausal advanced breast cancer: a meta-analysis of four randomized trials
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical and endocrine data for goserelin plus anastrozole as second-line endocrine therapy for premenopausal advanced breast cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Goserelin versus cyclophosphamide, methotrexate, and fluorouracil as adjuvant therapy in premenopausal patients with node-positive breast cancer: The Zoladex Early Breast Cancer Research Association Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Randomized adjuvant trial of tamoxifen and goserelin versus cyclophosphamide, methotrexate, and fluorouracil: evidence for the superiority of treatment with endocrine blockade in premenopausal patients with hormone-responsive breast cancer--Austrian
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Bone mineral density among premenopausal women with early breast cancer in a randomized trial of adjuvant endocrine therapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Luteinizing hormone-releasing hormone agonist triptorelin in combination with cytotoxic chemotherapy in patients with advanced ovarian carcinoma. A prospective double blind randomized trial. Decapeptyl Ovarian Cancer Study Group
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
D-TRP-6-LHRH (Triptorelin) is not effective in ovarian carcinoma: an EORTC Gynaecological Cancer Co-operative Group Study
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Phase II study of cetrorelix, a luteinizing hormone-releasing hormone antagonist in patients with platinum-resistant ovarian cancer.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
The effect of nafarelin acetate, a luteinizing-hormone-releasing hormone agonist, on benign prostatic hyperplasia
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Responses to the antagonistic analog of LH-RH (SB-75, Cetrorelix) in patients with benign prostatic hyperplasia and prostatic cancer
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Luteinizing hormone-releasing hormone (LH-RH) antagonist Cetrorelix inhibits growth of DU-145 human androgen-independent prostate carcinoma in nude mice and suppresses the levels and mRNA expression of IGF-II in tumors
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Rapid reduction of uterine myomas after short-term treatment with microencapsulated D-Trp6-LHRH
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of leiomyomata uteri with D-Trp6-luteinizing hormone-releasing hormone
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Intermittent leuprolide acetate for the nonsurgical management of women with leiomyomata uteri
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Estriol add-back therapy in the long-acting gonadotropin-releasing hormone agonist treatment of uterine leiomyomata
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Efficacy of pre-operative gonadotrophin hormone releasing analogues for women with uterine fibroids undergoing hysterectomy or myomectomy: a systematic review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Treatment of uterine leiomyomas with luteinizing hormone-releasing hormone antagonist Cetrorelix
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Preoperative reduction of uterine fibroids in only 16 days by administration of a gonadotrophin-releasing hormone antagonist (Cetrotide)
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
"Medical oophorectomy" using a long-acting GNRH agonist--a possible new approach to the treatment of endometriosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Use of GnRH antagonists in the treatment of endometriosis
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Induction of ovulation for in-vitro fertilisation using buserelin and gonadotropins
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Extrapituitary effects of GnRH antagonists in assisted reproduction: a review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Significant reduction of the incidence of ovarian hyperstimulation syndrome (OHSS) by using the LHRH antagonist Cetrorelix (Cetrotide) in controlled ovarian stimulation for assisted reproduction.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Prospective, randomized, controlled study of in vitro fertilization-embryo transfer with a single dose of a luteinizing hormone-releasing hormone (LH-RH) antagonist (cetrorelix) or a depot formula of an LH-RH agonist (triptorelin).
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
GnRH antagonist in assisted reproduction: a Cochrane review
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
D-Tryptophan-6 analog of luteinizing hormone-releasing hormone as a protective agent against testicular damage caused by cyclophosphamide in baboons
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Gonadal protection by a gonadotropin-releasing hormone agonist depot in young women with Hodgkin's disease undergoing chemotherapy
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
D-TRP5-analogue of luteinising hormone releasing hormone in combination with cyproterone acetate to treat precocious puberty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Clinical suppression of precocious puberty with cetrorelix after failed treatment with GnRH agonist in a girl with gonadotrophin-independent precocious puberty
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
An association of elevated serum gonadotropin concentrations and Alzheimer disease?
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Effective treatment of experimental human endometrial cancers with targeted cytotoxic luteinizing hormone-releasing hormone analogues AN-152 and AN-207.
1 reference
stated in
Crossref
reference URL
https://api.crossref.org/works/10.1038%2FNCPENDMET0399
retrieved
7 January 2021
based on heuristic
inferred from DOI database lookup
Identifiers
DOI
10.1038/NCPENDMET0399
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
PubMed publication ID
17237842
1 reference
stated in
Europe PubMed Central
PubMed publication ID
17237842
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:17237842%20AND%20SRC:MED&resulttype=core&format=json
retrieved
24 December 2019
Sitelinks
Wikipedia
(0 entries)
edit
Wikibooks
(0 entries)
edit
Wikinews
(0 entries)
edit
Wikiquote
(0 entries)
edit
Wikisource
(0 entries)
edit
Wikiversity
(0 entries)
edit
Wikivoyage
(0 entries)
edit
Wiktionary
(0 entries)
edit
Multilingual sites
(0 entries)
edit